NO20005418L - Homogeneous pharmaceutical compositions comprising abacavir, lamivudine and zidovudine - Google Patents
Homogeneous pharmaceutical compositions comprising abacavir, lamivudine and zidovudineInfo
- Publication number
- NO20005418L NO20005418L NO20005418A NO20005418A NO20005418L NO 20005418 L NO20005418 L NO 20005418L NO 20005418 A NO20005418 A NO 20005418A NO 20005418 A NO20005418 A NO 20005418A NO 20005418 L NO20005418 L NO 20005418L
- Authority
- NO
- Norway
- Prior art keywords
- abacavir
- lamivudine
- zidovudine
- pharmaceutical compositions
- homogeneous pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9809213.3A GB9809213D0 (en) | 1998-04-29 | 1998-04-29 | Pharmaceutical compositions |
| PCT/EP1999/002794 WO1999055372A1 (en) | 1998-04-29 | 1999-04-26 | Homogeneous pharmaceutical compositions comprising abacavir, lamivudine and zidovudine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20005418D0 NO20005418D0 (en) | 2000-10-27 |
| NO20005418L true NO20005418L (en) | 2000-11-29 |
Family
ID=10831228
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20005418A NO20005418L (en) | 1998-04-29 | 2000-10-27 | Homogeneous pharmaceutical compositions comprising abacavir, lamivudine and zidovudine |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP1083932A1 (en) |
| JP (1) | JP2002512979A (en) |
| KR (1) | KR20010043128A (en) |
| CN (1) | CN1411380A (en) |
| AP (1) | AP2000001971A0 (en) |
| AU (1) | AU4135599A (en) |
| BR (1) | BR9910071A (en) |
| CA (1) | CA2330391A1 (en) |
| EA (1) | EA200000997A1 (en) |
| EE (1) | EE200000646A (en) |
| GB (1) | GB9809213D0 (en) |
| HR (1) | HRP20000732A2 (en) |
| HU (1) | HUP0101622A3 (en) |
| ID (1) | ID26955A (en) |
| IL (1) | IL139181A0 (en) |
| IS (1) | IS5675A (en) |
| NO (1) | NO20005418L (en) |
| NZ (1) | NZ507745A (en) |
| PL (1) | PL343710A1 (en) |
| SK (1) | SK16212000A3 (en) |
| TR (1) | TR200003157T2 (en) |
| WO (1) | WO1999055372A1 (en) |
| ZA (1) | ZA200005922B (en) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6875773B1 (en) | 1998-05-29 | 2005-04-05 | Ben M. Dunn | Combination therapy for treatment of FIV infection |
| AU4219799A (en) * | 1998-05-29 | 1999-12-13 | University Of Florida | Combination therapy for treatment of fiv infection |
| GB9820417D0 (en) * | 1998-09-18 | 1998-11-11 | Glaxo Group Ltd | Antiviral combinations |
| US7074417B2 (en) * | 2000-10-13 | 2006-07-11 | Advancis Pharmaceutical Corporation | Multiple-delayed release anti-viral product, use and formulation thereof |
| US20050175694A1 (en) * | 2002-04-23 | 2005-08-11 | Himadri Sen | Long acting compositions comprising zidovudine and lamivudine |
| TW200403061A (en) * | 2002-06-04 | 2004-03-01 | Glaxo Group Ltd | Pharmaceutical compositions |
| CN100335125C (en) * | 2003-06-03 | 2007-09-05 | 上海现代药物制剂工程研究中心 | Interferon nasal spray powder with long service for detoxication and anti-bacteria |
| WO2006114709A1 (en) * | 2005-04-25 | 2006-11-02 | Aurobindo Pharma Limited | Pharmaceutical compositions of antiretrovirals |
| US20070059360A1 (en) * | 2005-07-29 | 2007-03-15 | Ashish Jaiswal | Water-dispersible anti-retroviral pharmaceutical compositions |
| ES2279707B1 (en) * | 2005-11-10 | 2008-06-01 | Combino Pharm, S.L. | ORAL FORMULATIONS THAT INCLUDE 3'-AZIDONUCLEOSIDS. |
| BRPI0816498A2 (en) * | 2007-10-02 | 2019-02-26 | Emory University | potent combinations of zidovudine and drugs that select for k65r mutation in hiv polymerase |
| GB2470494B (en) * | 2008-01-17 | 2012-08-08 | Univ Holy Ghost Duquesne | Antiretroviral drug formulations for treatment of children exposed to HIV/AIDS |
| LT3494972T (en) * | 2010-01-27 | 2024-03-12 | Viiv Healthcare Company | Combinations of dolutegravir and lamivudine for the treatment of hiv infection |
| CN114010776A (en) | 2010-06-09 | 2022-02-08 | 疫苗技术股份有限公司 | Therapeutic immunization of HIV-infected persons for enhancing antiretroviral therapy |
| RU2014140177A (en) | 2012-03-05 | 2016-04-27 | Сипла Лимитед | PHARMACEUTICAL ANTIRETROVIRAL COMPOSITIONS |
| AU2013336491B2 (en) | 2012-10-23 | 2018-08-02 | Cipla Limited | Pharmaceutical antiretroviral composition |
| JP2016521747A (en) | 2013-06-13 | 2016-07-25 | アケビア セラピューティクス インコーポレイテッドAkebia Therapeutics Inc. | Compositions and methods for the treatment of anemia |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY115461A (en) * | 1995-03-30 | 2003-06-30 | Wellcome Found | Synergistic combinations of zidovudine, 1592u89 and 3tc |
| GB9622681D0 (en) * | 1996-10-31 | 1997-01-08 | Glaxo Group Ltd | Pharmaceutical compositions |
-
1998
- 1998-04-29 GB GBGB9809213.3A patent/GB9809213D0/en not_active Ceased
-
1999
- 1999-04-26 KR KR1020007012021A patent/KR20010043128A/en not_active Withdrawn
- 1999-04-26 EP EP99924822A patent/EP1083932A1/en not_active Withdrawn
- 1999-04-26 AU AU41355/99A patent/AU4135599A/en not_active Abandoned
- 1999-04-26 HU HU0101622A patent/HUP0101622A3/en unknown
- 1999-04-26 BR BR9910071-1A patent/BR9910071A/en not_active IP Right Cessation
- 1999-04-26 CN CN99807983A patent/CN1411380A/en active Pending
- 1999-04-26 AP APAP/P/2000/001971A patent/AP2000001971A0/en unknown
- 1999-04-26 IL IL13918199A patent/IL139181A0/en unknown
- 1999-04-26 ID IDW20002479A patent/ID26955A/en unknown
- 1999-04-26 EE EEP200000646A patent/EE200000646A/en unknown
- 1999-04-26 SK SK1621-2000A patent/SK16212000A3/en unknown
- 1999-04-26 PL PL99343710A patent/PL343710A1/en unknown
- 1999-04-26 HR HR20000732A patent/HRP20000732A2/en not_active Application Discontinuation
- 1999-04-26 EA EA200000997A patent/EA200000997A1/en unknown
- 1999-04-26 NZ NZ507745A patent/NZ507745A/en unknown
- 1999-04-26 CA CA002330391A patent/CA2330391A1/en not_active Abandoned
- 1999-04-26 TR TR2000/03157T patent/TR200003157T2/en unknown
- 1999-04-26 JP JP2000545569A patent/JP2002512979A/en active Pending
- 1999-04-26 WO PCT/EP1999/002794 patent/WO1999055372A1/en not_active Ceased
-
2000
- 2000-10-20 IS IS5675A patent/IS5675A/en unknown
- 2000-10-23 ZA ZA200005922A patent/ZA200005922B/en unknown
- 2000-10-27 NO NO20005418A patent/NO20005418L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU4135599A (en) | 1999-11-16 |
| IL139181A0 (en) | 2001-11-25 |
| CA2330391A1 (en) | 1999-11-04 |
| GB9809213D0 (en) | 1998-07-01 |
| AP2000001971A0 (en) | 2000-12-31 |
| ZA200005922B (en) | 2001-10-23 |
| EE200000646A (en) | 2002-04-15 |
| ID26955A (en) | 2001-02-22 |
| HRP20000732A2 (en) | 2001-02-28 |
| WO1999055372A1 (en) | 1999-11-04 |
| JP2002512979A (en) | 2002-05-08 |
| IS5675A (en) | 2000-10-20 |
| CN1411380A (en) | 2003-04-16 |
| EP1083932A1 (en) | 2001-03-21 |
| EA200000997A1 (en) | 2001-06-25 |
| SK16212000A3 (en) | 2001-07-10 |
| BR9910071A (en) | 2000-12-26 |
| KR20010043128A (en) | 2001-05-25 |
| TR200003157T2 (en) | 2001-01-22 |
| NZ507745A (en) | 2004-07-30 |
| PL343710A1 (en) | 2001-08-27 |
| NO20005418D0 (en) | 2000-10-27 |
| HUP0101622A3 (en) | 2003-09-29 |
| HUP0101622A2 (en) | 2002-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20005418D0 (en) | Homogeneous pharmaceutical compositions comprising abacavir, lamivudine and zidovudine | |
| DK1095016T3 (en) | Sulfur-substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical compositions comprising them | |
| EA199900373A3 (en) | PHARMACEUTICAL COMPOSITIONS | |
| NO20002359L (en) | Adenosine derivatives and pharmaceutical composition containing the derivatives | |
| NO20001409L (en) | Carboxamidothiazole derivatives, processes for their preparation and pharmaceutical compositions | |
| DK1582592T3 (en) | Corn transformant PV-ZMGT32 (NK6039 and compositions and methods for detection thereof | |
| NO20024355L (en) | Nucleoside Compounds and Uses thereof | |
| NO20005913D0 (en) | Medicinal Composition | |
| DE69904492D1 (en) | COMPUTER GAME | |
| ID26549A (en) | EPOTILON COMPOSITIONS | |
| ATE367793T1 (en) | SWEAT-INHIBITING COMPOSITIONS | |
| DK1112266T3 (en) | Substituted 4-amino-2-arylpyrimidines, their preparation and use, and pharmaceutical compositions containing them | |
| ATE469550T1 (en) | ANTIPARASIC COMPOSITIONS | |
| NO20006488D0 (en) | Composition and application | |
| DE69927758D1 (en) | Imidosilane compositions | |
| DE69807911D1 (en) | NETWORKABLE COMPOSITION | |
| NO20004160D0 (en) | Cross country or cross country skiing | |
| ID27201A (en) | PHARMACEUTICAL COMPOSITION | |
| IS5827A (en) | Muskrin agonists and antidotes | |
| IS6677A (en) | Aminoalkylbenzoyl-benzofuran or benzothiophene derivatives, processes for their preparation and compositions containing them | |
| ID27889A (en) | POLYCLIC COOPOLYMER COMPOSITIONS | |
| FR2787721B1 (en) | EXTINGUISHING COMPOSITIONS | |
| ID22405A (en) | PESTICIDE COMPOSITION | |
| IS5024A (en) | Pharmaceutical formulations containing lamivudine and zidovudine | |
| DE69820498D1 (en) | Fungicidal mixture containing an N-acetonylbenzamide and fluazinam |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |